{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:55:57Z","timestamp":1789232157207,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Remdesivir was not approved in patients with eGFR &lt;30 ml\/min per 1.73 m\n                            <jats:sup>2<\/jats:sup>\n                            , and safety data are extremely limited.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Compared with matched controls who did not receive remdesivir, there was no increased risk of cardiac, kidney, liver, or neurologic adverse events.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Hyperglycemia was more common in remdesivir-treated patients; this may be explained by concomitant dexamethasone use.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Remdesivir is not currently approved for patients with eGFR &lt;30 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      . We aimed to determine the safety of remdesivir in patients with kidney failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study was a retrospective cohort study of patients with COVID-19 hospitalized between May 2020 and January 2021 with eGFR &lt;30 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      who received remdesivir and historical controls with COVID-19 hospitalized between March 1, 2020 and April 30, 2020 prior to the emergency use authorization of remdesivir within a large health care system. Patients were 1:1 matched by propensity scores accounting for factors associated with treatment assignment. Adverse events and hospital outcomes were recorded by manual chart review.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall cohort included 34 hospitalized patients who initiated remdesivir within 72 hours of hospital admission with eGFR&lt;30 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      and 217 COVID-19 controls with eGFR &lt;30 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      . The propensity score\u2013matched cohort included 31 remdesivir-treated patients and 31 nonremdesivir-treated controls. The mean age was 74.0 (SD=13.8) years, 57% were women, and 68% were white participants. A total of 26% had ESKD. Among patients who were not on dialysis prior to initiating remdesivir, one developed worsening kidney function (defined as \u226550% increase in creatinine or initiation of KRT) compared with three in the historical control group. There was no increased risk of cardiac arrythmia, cardiac arrest, altered mental status, or clinically significant anemia or liver function test abnormalities. There was a significantly increased risk of hyperglycemia, which may be partly explained by the increased use of dexamethasone in the remdesivir-treated population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In this propensity score\u2013matched study, remdesivir was well tolerated in patients with eGFR &lt;30 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0006152021","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T17:45:13Z","timestamp":1638553513000},"page":"269-278","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["A Propensity Score\u2013Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease"],"prefix":"10.34067","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5316-4610","authenticated-orcid":false,"given":"Rituvanthikaa","family":"Seethapathy","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Strohbehn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4327-9713","authenticated-orcid":false,"given":"Meghan E.","family":"Sise","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B2-20250825","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N Engl J Med"},{"key":"B3-20250825","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"B4-20250825","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","article-title":"Acute kidney injury in patients hospitalized with COVID-19","volume":"98","author":"Hirsch","year":"2020","journal-title":"Kidney Int"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"614","DOI":"10.34067\/KID.0002652020","article-title":"Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans","volume":"1","author":"Mohamed","year":"2020","journal-title":"Kidney360"},{"key":"B7-20250825","doi-asserted-by":"crossref","first-page":"m4677","DOI":"10.1136\/bmj.m4677","article-title":"Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: Cohort study","volume":"371","author":"Xie","year":"2020","journal-title":"BMJ"},{"key":"B8-20250825","doi-asserted-by":"crossref","first-page":"e0244131","DOI":"10.1371\/journal.pone.0244131","article-title":"High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy","volume":"15","author":"Stevens","year":"2020","journal-title":"PLoS One"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ekir.2020.06.013","article-title":"Outcomes for patients with COVID-19 and acute kidney injury: A systematic review and meta-analysis","volume":"5","author":"Robbins-Juarez","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B10-20250825","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ekir.2021.01.036","article-title":"Decreasing incidence of acute kidney injury in patients with COVID-19 critical illness in New York City","volume":"6","author":"Charytan","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B11-20250825","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.xkme.2021.06.008","article-title":"Acute kidney injury in patients hospitalized with COVID-19 in New York City: Temporal trends from March 2020 to April 2021","volume":"3","author":"Dellepiane","year":"2021","journal-title":"Kidney Med"},{"key":"B12-20250825","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2020050615","article-title":"AKI in hospitalized patients with COVID-19","volume":"32","author":"Chan","year":"2021","journal-title":"J Am Nephrol Soc"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ajkd.2020.09.003","article-title":"Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States","volume":"77","author":"Flythe","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1681\/ASN.2020050589","article-title":"Remdesivir in patients with acute or chronic kidney disease and COVID-19","volume":"31","author":"Adamsick","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B16-20250825","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","article-title":"Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: More accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions","volume":"55","author":"Levey","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B17-20250825","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archinternmed.2011.677","article-title":"Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism","volume":"172","author":"Rhee","year":"2012","journal-title":"Arch Intern Med"},{"key":"B18-20250825","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jamainternmed.2013.9774","article-title":"A risk prediction score for kidney failure or mortality in rhabdomyolysis","volume":"173","author":"McMahon","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"B20-20250825","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"B21-20250825","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum","year":"1985","journal-title":"Am Stat"},{"key":"B22-20250825","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"B23-20250825","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"B24-20250825","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2020.8193","article-title":"Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic","volume":"181","author":"Asch","year":"2021","journal-title":"JAMA Intern Med"},{"key":"B25-20250825","doi-asserted-by":"crossref","first-page":"791.e5","DOI":"10.1016\/j.cmi.2021.02.013","article-title":"Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): A new safety concerns","volume":"27","author":"Touafchia","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"B26-20250825","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ekir.2020.10.005","article-title":"Safety of remdesivir in patients with acute kidney injury or CKD","volume":"6","author":"Thakare","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B27-20250825","doi-asserted-by":"crossref","first-page":"e3990","DOI":"10.1093\/cid\/ciaa1851","article-title":"Remdesivir use in the setting of severe renal impairment: A theoretical concern or real risk?","volume":"73","author":"Pettit","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B28-20250825","doi-asserted-by":"crossref","first-page":"e02290-20","DOI":"10.1128\/AAC.02290-20","article-title":"A valid warning or clinical lore: An evaluation of safety outcomes of remdesivir in patients with impaired renal function from a multicenter matched cohort","volume":"65","author":"Ackley","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"B29-20250825","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ekir.2020.12.003","article-title":"Use of remdesivir in patients with COVID-19 on hemodialysis: A study of safety and tolerance","volume":"6","author":"Aiswarya","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B30-20250825","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ekir.2020.11.025","article-title":"Remdesivir in patients with estimated GFR <30 ml\/min per 1.73 m2 or on renal replacement therapy","volume":"6","author":"Estiverne","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B31-20250825","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.kint.2021.02.015","article-title":"Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: A retrospective case-noncase study","volume":"99","author":"Chouchana","year":"2021","journal-title":"Kidney Int"},{"key":"B32-20250825","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/cpt.2145","article-title":"Remdesivir and acute renal failure: A potential safety signal from disproportionality analysis of the WHO safety database","volume":"109","author":"G\u00e9rard","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"B33-20250825","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ekir.2021.04.032","article-title":"Osmotic tubulopathy in a patient with COVID-19 treated with remdesivir","volume":"6","author":"Wongboonsin","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B34-20250825","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ekir.2021.07.008","article-title":"Acute kidney injury incidence, recovery, and long-term kidney outcomes among hospitalized patients with COVID-19 and influenza","volume":"6","author":"Strohbehn","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B35-20250825","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2147\/CIA.S313028","article-title":"Remdesivir, renal function and short-term clinical outcomes in elderly COVID-19 pneumonia patients: A single-centre study","volume":"16","author":"Biancalana","year":"2021","journal-title":"Clin Interv Aging"},{"key":"B36-20250825","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.ekir.2021.06.023","article-title":"Use and safety of remdesivir in kidney transplant recipients with COVID-19","volume":"6","author":"Buxeda","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B37-20250825","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1681\/ASN.2020060877","article-title":"The exclusion of patients with CKD in prospectively registered interventional trials for COVID-19: A rapid review of international registry data","volume":"31","author":"Major","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B38-20250825","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ekir.2020.10.010","article-title":"Phase-3 randomized controlled trials on exclusion of participants with kidney disease in COVID-19","volume":"6","author":"Chewcharat","year":"2021","journal-title":"Kidney Int Rep"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0006152021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:57:48Z","timestamp":1786478268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0006152021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0006152021","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"2021-09-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}